Benign Reactive Giant-Cell Lesion of Small Bones
- GIANT CELL REPARATIVE GRANULOMA (GCRG) is a BENIGN, REACTIVE giant-cell-rich lesion (not a true neoplasm) that most often arises in the SMALL BONES of the HANDS and FEET and in the JAWS (where it is termed central giant cell granuloma); it is now generally regarded as part of the spectrum of GIANT-CELL LESIONS OF THE SMALL BONES (overlapping with the 'solid' aneurysmal bone cyst).
- It presents as a LYTIC, often EXPANSILE lesion of a small tubular bone with cortical thinning and can look locally aggressive on imaging, but it is benign; pain, swelling and sometimes pathological fracture are typical.
- HISTOLOGICALLY it shows a FIBROUS/cellular stroma containing osteoclast-type GIANT CELLS that are distributed UNEVENLY - clustered, often around foci of HAEMORRHAGE - together with REACTIVE woven BONE and haemosiderin; this UNEVEN, clustered giant-cell pattern (with reactive bone) helps distinguish it from giant cell tumour of bone, in which the giant cells are large and EVENLY distributed throughout a mononuclear stroma.
- The crucial DIFFERENTIAL is GIANT CELL TUMOUR (GCT) OF BONE, which is locally aggressive and - importantly - RARE in the small bones of the hand (it favours the meta-epiphysis of long bones around the knee); according to PubMed a giant-cell-rich lesion of the distal phalanx initially diagnosed as GCRG can recur and prove to be a giant cell tumour, so the diagnosis can be challenging and warrants experienced pathological review.
- Other DIFFERENTIALS to consider for a giant-cell-rich lytic lesion of a small bone include the BROWN TUMOUR of hyperparathyroidism (check calcium/PTH), ANEURYSMAL BONE CYST, and (rarely) more aggressive lesions - so biochemistry and correlation of imaging with histology are part of the work-up.
- MANAGEMENT is CURETTAGE (with bone grafting) for most lesions, which is usually effective, but there is a NOTABLE LOCAL RECURRENCE rate, so follow-up is needed and recurrent or aggressive lesions may require more extensive excision (occasionally amputation of a digit) and confirmation of the diagnosis - because a 'recurrent GCRG' may turn out to be a giant cell tumour.
- “Giant cell reparative granuloma = BENIGN, REACTIVE giant-cell lesion of the SMALL BONES of the hands/feet (and JAWS = central giant cell granuloma); part of the giant-cell-lesion-of-small-bones / solid ABC spectrum.
- “Histology: fibrous stroma + UNEVENLY/clustered giant cells around HAEMORRHAGE + reactive bone (vs GCT of bone = large, EVENLY distributed giant cells).
- “Key differential = giant cell tumour of bone (locally aggressive, RARE in the hand). Also brown tumour (check Ca/PTH), ABC. Treat by curettage +/- grafting; notable recurrence - follow up (a 'recurrent GCRG' may be a GCT).
Small bones of hands/feet (and jaws); fibrous stroma with unevenly clustered giant cells around haemorrhage + reactive bone. Curettage (can recur).
Rare in the hand; locally aggressive; large, evenly distributed giant cells in a mononuclear stroma. A 'recurrent GCRG' may prove to be a GCT - review carefully.
Features, Histology & Differential
GCRG is a benign, reactive giant-cell-rich lesion (not a true neoplasm), most often of the small bones of the hands/feet and the jaws (central giant cell granuloma), within the giant-cell-lesion-of-small-bones / solid ABC spectrum. It is lytic and expansile with cortical thinning and can look aggressive but is benign. Histology shows a fibrous stroma with unevenly distributed/clustered osteoclast-type giant cells (often around haemorrhage) plus reactive woven bone and haemosiderin - distinguishing it from giant cell tumour of bone (large, evenly distributed giant cells; locally aggressive; rare in the hand). Also consider the brown tumour of hyperparathyroidism (check calcium/PTH) and aneurysmal bone cyst.
| Feature | Giant cell reparative granuloma | Giant cell tumour of bone |
|---|---|---|
| Nature | Benign, reactive | Benign but locally aggressive neoplasm |
| Typical site | Small bones of hands/feet; jaws | Meta-epiphysis of long bones (around knee); rare in hand |
| Giant-cell distribution | Uneven/clustered (around haemorrhage) | Large, evenly distributed throughout stroma |
| Other histology | Fibrous stroma, reactive woven bone, haemosiderin | Mononuclear stromal cells (the neoplastic component) |
| Treatment | Curettage (+/- grafting); can recur | Extended curettage +/- adjuvants; denosumab; recurrence |
Management
- Work-up: imaging (lytic/expansile small-bone lesion); biochemistry (calcium/PTH to exclude a brown tumour); biopsy/histology at a centre experienced in bone tumours.
- Treatment: curettage with bone grafting for most lesions - usually effective.
- Follow up: there is a notable local recurrence rate.
- Recurrent/aggressive disease: more extensive excision (occasionally digital amputation) and re-confirm the diagnosis - a 'recurrent GCRG' may prove to be a giant cell tumour of bone.
The practical trap with giant cell reparative granuloma is diagnostic overlap with other giant-cell-rich lesions, especially giant cell tumour of bone. GCRG is a benign, reactive lesion of the small bones of the hands and feet (and jaws), with a fibrous stroma and unevenly clustered giant cells around haemorrhage and reactive bone, and it is treated by curettage and grafting. Giant cell tumour of bone, by contrast, is a locally aggressive neoplasm with large, evenly distributed giant cells, and it is rare in the hand - so a giant-cell-rich lesion of a phalanx diagnosed as GCRG that then recurs should prompt re-review of the histology, because it may in fact be a giant cell tumour requiring different, more aggressive management. The work-up should also exclude the brown tumour of hyperparathyroidism with calcium and PTH, and aneurysmal bone cyst is in the spectrum. Because GCRG has a notable recurrence rate, follow-up is needed, and recurrent or aggressive lesions warrant both more extensive surgery and a fresh, experienced pathological assessment of the diagnosis.
Evidence & Key Studies
Giant-cell lesion of the distal phalanx initially diagnosed as reparative granuloma, recurring as giant cell tumour
- Giant cell tumours of bone are locally aggressive neoplasms that typically occur in the distal femur or proximal tibia and infrequently in the bones of the hand, including the distal phalanx.
- A distal-phalanx lesion underwent curettage with a working diagnosis of giant cell reparative granuloma (with focal fracture callus), but recurred at 8 months and, on histopathology, was confirmed to be a giant cell tumour of bone (requiring amputation of the distal phalanx tip).
- In rare and difficult-to-diagnose giant-cell lesions, consultation with experienced pathologists improves diagnostic accuracy and prevents treatment delays - underscoring the GCRG/GCT diagnostic overlap.
According to PubMed, the diagnostic overlap and challenge between giant cell reparative granuloma and giant cell tumour of bone in the small bones of the hand (a phalangeal lesion diagnosed as GCRG recurring and proving to be a giant cell tumour), the rarity of giant cell tumour in the hand, and the value of experienced pathological review come from the cited DeFrancisis report. The benign reactive nature of GCRG, its location in the small bones of the hands/feet and jaws, the histological distinction (uneven/clustered giant cells with reactive bone vs even distribution in GCT), the brown-tumour/ABC differentials, and curettage-with-recurrence management are standard, well-established teaching. (See also our Giant Cell Tumour of Bone, Aneurysmal Bone Cyst and Brown Tumour / Hyperparathyroidism topics.)
Clinical Decision Scenarios
Practise clinical reasoning and management decisions out loud
“A lytic, expansile lesion of a phalanx shows a giant-cell-rich histology. How do you approach the diagnosis and management?”
Mnemonics & Memory Aids
REPAIR
Hook:REPAIR: Reactive benign, Extremity small bones/jaws, Pattern (uneven/clustered + reactive bone), vs GCT (even/aggressive), Investigate Ca/PTH, Resect/curette + Recurrence (re-confirm).
What it is
- Benign, reactive giant-cell-rich lesion (not a true neoplasm)
- Small bones of hands/feet and the jaws (central giant cell granuloma)
- Part of the giant-cell-lesion-of-small-bones / solid ABC spectrum
Histology
- Fibrous/cellular stroma; unevenly distributed/clustered giant cells
- Often around foci of haemorrhage; reactive woven bone + haemosiderin
- Contrast: GCT of bone = large, evenly distributed giant cells
Differential & work-up
- Giant cell tumour of bone (locally aggressive; rare in hand)
- Brown tumour (check calcium/PTH); aneurysmal bone cyst
- Imaging + biochemistry + experienced histology review
Management
- Curettage (+/- grafting) - usually effective
- Notable recurrence rate - follow up
- Recurrent/aggressive: re-confirm diagnosis (may be GCT) + more extensive surgery